Top searches

PL

Resources

B2RLaw advised Life Science Innovation Fund on its investment in a healthtech startup

23/10/2020

B2RLaw has advised the Life Science Innovation Fund on its investment in AIDLAB, a telemedical startup. The aim of the investment is to develop a new product, AIDMED, a device which remotely diagnoses diseases, particularly sleep breathing and cardiac disorders.

The healthtech industry is experiencing noticeable growth during the current pandemic. Innovative solutions that allow certain activities to be performed remotely are relieving the burden on medical personnel while providing more comfortable conditions for patients. AIDMED’s solutions can reduce hospitalization periods to a minimum using artificial intelligence to analyze measurements.

The investor is a Polish VC, Life Science Innovation Fund, which invests in MedTech, Biotech and Health Care, and has invested in a number of successful companies such as BrainScan, Bioseco, LumiSep and LifeFlow.

B2RLaw’s consisted of Partner Szymon Syp, Ph.D. and Senior Associate Iga Wojtczak-Opala.

View more resources

Catch up on the very latest B2RLAW
announcements and news here.

10/01/2023

B2RLaw advises Polish unicorn DocPlanner on its acquisition of MyDr

B2RLaw has advised Polish unicorn DocPlanner on its acquisition of MyDr – DocPlanner’s first acquisition on the Polish market. Docplanner […]

MORE
02/01/2023

New Compliance 360 practice at B2RLaw

B2RLaw has established a multidisciplinary team whose aim is to support clients in monitoring and adapting their activities to the […]

MORE
28/11/2022

B2RLaw advises on the sale of award-winning Gdynia office complex

B2RLaw has advised the sellers (a Dutch company and Polish companies) on the sale of Łużycka Office Park (buildings A, […]

MORE
15/11/2022

B2RLaw advises SaaS-enabled B2B marketplace for the healthcare industry, Dentametr, on a pre-seed round with investors, which includes Octopus Ventures

B2RLaw has advised Dentametr and its founders on its pre-seed round capital raise with investors including leading investment fund Octopus […]

MORE
08/11/2022

B2RLaw advises Auxilius Pharma on capital raise to fuel groundbreaking growth to the US market

B2RLaw advised Auxilius Pharma Sp. z o.o. and its founders on a venture capital transaction related to the investment of […]

MORE
03/11/2022

B2RLaw advises Westcoast on merger to create EUR 5.5 billion ICT distributor

B2RLaw has advised the UK’s largest privately owned information and communications technology company Westcoast on Polish aspects of its merger […]

MORE

Get in touch

Not sure who to contact? Let us help you find the right lawyer.

This site uses cookies to improve your experience More information.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close